Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc/ US98956P1021 /
ZBH
|
9/28/2023 9:59:56 PM
|
Chg.
+1.68
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
112.45USD
|
+1.52%
|
99,183
Turnover: 11.17 mill. |
-Bid Size: - |
-Ask Size: - |
23.5 bill.USD |
0.85% |
102.24 |
Business description
Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Management board & Supervisory board
| CEO |
| Bryan C. Hanson |
| Management board |
| Suketu Upadhyay, Rachel Ellingson, David J. Kunz, Angela Main, Keri P. Mattox, Chad Phipps, Paul Stellato, Zeeshan Tariq, Ivan Tornos, Kenneth R. Tripp, Lori Winkler, Sang Yi, Wilfred van Zuilen |
| Supervisory board |
| Bryan C. Hanson, Arthur J. Higgins, Christopher B. Begley, Maria Teresa Hilado, Michael J. Farrell, Michael W. Michelson, Robert A. Hagemann, Sreelakshmi Kolli, Syed Jafry, Betsy J. Bernard |
Company data
| Name: |
Zimmer Biomet Holdings Inc. |
| Address: |
345 East Main Street,Warsaw, Indiana 46580, USA |
| Phone: |
+1-574-373-3121 |
| Fax: |
- |
| E-mail: |
surveys@zimmerbiomet.com
|
| Internet: |
www.zimmerbiomet.com/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
74.90% |
| IPO date: |
- |